##
##
##
##
|||Page|
|---|---|---|
|Legal and Administrative
information|||
|Report ofthe Executive Committee||2to ll|
|Independent
Auditors|Report to the Members|12to 14|
|Statement ofFinancial|Activities|15|
|Balance Sheet||16|
|Cash Flow Statement||17|
|Notes to the Financial|Statements|18to 29|
##
##
|||||||||
|---|---|---|---|---|---|---|---|
|LEGAL|AND A|DMINI|TRATIVE
INFORMATION||||Page l|
|Charity|number:||1111382|||||
|Company|number:||05540014|||||
|Trustees|aad Executive||Committee
members at 30September 2020:|||||
||||Dr CElton —President|||||
||||Dr KLitchfield - Honorary|||Secretary||
||||Dr EEvans —Honorary||Secretary Elect (from 27 June 2020)|||
||||DrJBamber - Honorary||Treasurer|||
||||Dr S Armstrong|||||
||||DrJCampbell
(Appointed|||27June 2020)||
||||Dr R Collie|||||
||||Dr KMaclennan|||||
||||Dr F Pearson|||||
||||Dr RRussell|||||
||||Dr R Sodhi|||||
||||Dr M Van de Velde|||||
|Other Committee||members|(non-voting)
at30September|2020:||||
||||Dr N Lucas|||||
||||Dr FPleat —Royal College|||ofAnaesthetists|(RCoA)|
||||representative
(Resigned||as|Trustee 27June|2020)|
||||Ms SStanford|||||
|Registered|office.||21 Portland Place|||||
||||London|||||
||||W(B JPY|||||
|Beakers:|||National
Westminster|Bank||pic||
||||)49 Church Street|||||
||||Bames|||||
||||London
SW139HS|||||
||||Scottish Widows|||||
||||15Dalkeith Road|||||
||||Edinburgh
EH16 5BU|||||
|Auditors:|||Moore (South) LLP|||||
||||Priory House|||||
||||Pilgrims
Court|||||
||||Sydenham
Road|||||
||||Guildford|||||
||||Surrey
GUl 3RX|||||
|Investmeat|Managers:||Charles Stanley &Co.|Limited||||
||||55 Bishopsgate|||||
||||London|||||
||||EC2N 3AS|||||
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|Ol Grant June 2019|Ol Grant June 2019|Ol Grant June 2019|||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|EPowell|||Tackling|Antenatal|||Anaemia:||A|multi-faceted|||approach|||||f1,748|
|OAA Small Grant Sept 2019|||||||||||||||||||
|L Kessack|||Observational||study of|||peripheral||skin|temperature||||changes|||,985|
||||following|spinal||anaestbesia|||for|category||4 lower|||segment||||
||||caesarean|section|||LSCS||||||||||||
|International|Grants September 2019||||||||||||||||||
|TBleeser|||Disentangling||the||effects of anaesthesia|||||from||those||of non-||f6,122|
||||obstetric|surgery||in|the|rabbit|model||||||||||
|M Van de Velde|||High
volume||PCEA|||versus|PIEB||for|labor|||analgesia:||a|f4,670|
||||randomized,||double||blind, multicenter,||||non-inferiority|||||study|in||
||||nulli
arous women||||||||||||||||
|Travel Grants|April|2020|||||||||||||||||
|Two travel grants awarded|||forf750.||||||||||||||||
|SOAP Bursary|2020||||||||||||||||||
|None awarded|||||||||||||||||||
|3 Day Course Bursaries 2020|||||||||||||||||||
|None awarded|||||||||||||||||||
|OAA Small Research||Grants 2020|||||||||||||||||
|Analytics
Cambridge||Ltd|Data Analysis||work||NOAD|||||||||||f1,200|
|None awarded|||||||||||||||||||
##
##
##
##
##
##
##
##
##
||||||20IG|2017|2018|2019|2020|
|---|---|---|---|---|---|---|---|---|---|
||||||Actual|Actual|Aet sl|~Actual|Aciual|
|OAA snbscnption
income|||||236,431|239,508|242,2G5|232,090|230,70G|
|less: IIOA and Pencil Point|publishing|||costi|(91,418)|(93,706)|(93,185)|(94,170)|(91,767)|
|less
PCH memberslnp
admimstrstion||||costs|(14,151)|(12,737)|(4,803)|(1,570)|(780)|
|less: AAGBI admmistrntion|costs||||(97,060)|(114,691)|( H 8,207)|(132,249)|(126,726)|
|Contributinn
tn overheads|||||334102|18474|26,070|3,921|11,433|
|Surplus
on nieetings
including||sponsorship|||137,727|174,659|102,420|40,3&i6|6,493|
|aesearch
grants payable|||||(88,822)|(76,139)|(158,209)|(170,133)|( I 8,725)|
|Travel
snd
Outreach
Meetings||||grants|(4,500)|(4,000)|(5,000)|(3,750)|(750)|
|payable||||||||||
|Bursaries|||||(14,744)|(19,243)|(13,224)|(18,300)|(1,018)|
|Grants written
back|||||2,596|28,457|2,452|16,533|3,866|
|Dona@our payable|||||(13,500)|(1.000)|(1,575)|(311)|(685)|
|Contribution
to overheads|||||18.757|102,734|(73,136)|(135/95)|(10819)|
|Other income|||||118,735|117,443|111,289|112,680|128,408|
|Nct income befure other expenditure|||||171,294|238,G51|64423|(18,994)|129,022|
|Orher
direct
costs
(panting,|||videos,||(1,512)|(234)||||
|educutuin
etc)||||||||||
|Management,
administration||||and|(129,625)|(99,605)|(88,670)|(116,237)|(79,166)|
|governance||||||||||
|Net surplus/(deficit)
for year|||||40,157|138,812|(24,447)|(135,231)|494156|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
||||Notes|Total|Total|
|---|---|---|---|---|---|
|||||Uarestricted|Unrestricted|
|||||Funds|Funds|
|||||2020|2019|
|INCOME FROM||||||
|Charitable
activities|||3|237,890|459,570|
|Other trading activities|||4|326,090|307,084|
|Investment
income|||5|33,024|37,686|
|Total income||||597,004|804,340|
|EXPENDITURE ON||||||
|Raising funds||||11,526|6,739|
|Charitable
activities||||519,382|922,638|
|Other||||16,240|10,194|
|Total expenditure||||547,148|939,571|
|Net (losses)/gains
on investments|||14|(8,294)|55,254|
|Net incoming/(outgoing)||resources||41,562|(79,977)|
|Net movement
in fuads||||41,562|(79,977)|
|Reconciliation offunds||||||
|Total funds brought|forward||19|1,579,241|1,659,2I8|
|Total Funds Carried Forward|||19|1,620,803|1,579,241|
##
||||||2020||2019||
|---|---|---|---|---|---|---|---|---|
|||||Note|||||
|Fixed assets|||||||||
|Investments||||14||1,321,407||1,308,487|
|Current assets|||||||||
|Debtors||||15|257,733||215,559||
|Cash at bank|and in|hand|||294,961||555,667||
||||||552,694||771,226||
|Creditors: Amounts||falling due|||||||
|within oae year||||16|253,298||500,472||
|Net current|assets|||||299,396||270,754|
|Total assets|less current||liabilities|||1,620,803||1,579,241|
|Charity Funds|||||||||
|Unrestricted|Funds|||18||1,620,803||1,579,241|
##
|OBSTETRIC ANAESTHETISTS A
(A Company
Limited By Guarantee)|OBSTETRIC ANAESTHETISTS A
(A Company
Limited By Guarantee)|OBSTETRIC ANAESTHETISTS A
(A Company
Limited By Guarantee)|OBSTETRIC ANAESTHETISTS A
(A Company
Limited By Guarantee)|OBSTETRIC ANAESTHETISTS A
(A Company
Limited By Guarantee)|SSOCIATI|ON|||
|---|---|---|---|---|---|---|---|---|
|STATEMENT OF CASH FLOWS||||||||Page 17|
|YEAR ENDED 30TH SEPTEMBER 2020|||||||||
||||||2020||2019||
|||||Note|||||
|Cash Ilows from operating||activities|||||||
|Net cash provided
by operating|||||||||
|activities||||21||(272,340)||(89,422)|
|Cash flows from investing||activities|||||||
|Dividends
received|||||32,848||37,686||
|Proceeds from sale ofinvestments|||||102,130||85,378||
|Purchase ofinvestments|||||(24,608)||(104,908)||
|Net cash used in investing|activities|||||110,370||18,156|
|Change
in cash and cash||equivalents|||||||
|in the reporting
period||||||(161,970)||(71,266)|
|Cash
and
cash
equivalents|||at|the|||||
|beginning ofthe reporting|period|||||620,797||692,063|
|Cash aad cash equivalents||at tbe end|||||||
|ofthe reporting
period||||||458,827||620,797|
|Analysis ofcash and cash||equivalents|||||||
|||||||2020||2019|
|||||||8||8|
|Cash at bank and in hand||||||294,961||555,667|
|Cash held by stockbroker||||||163,866||65,130|
|Total cash and cash equivalents||||||458,827||620,797|
##
##
##
##
##
##
##
##
##
|
|
|
||
|---|---|---|---|
|NO|TES TO THK FINANCIAL STATEMENTS (CONTINUED)||Page 21|
|YEAR ENDED 30TH SEPTEMBER2020||||
|4.|INCOME FROM OTHER TRADING ACTIVITIES|||
|||2020|2019|
||OAA subscriptions|230,706|232,090|
||Royalties|94,184|74,294|
||Other income|1,200|700|
|||326,090|307,084|
|5.|INCOME FROM INVESTMENTS|||
|||2020|2019|
||||8|
||Dividends|32,848|37,686|
||Bank interest|176||
|||33,024|37,686|
|6.|RAISING FUNDS|||
|||2020|2019|
||Investment
Managerfees|11,526|6,739|
|7.|DIRECT CHARITABLE EXPENDITURE|||
|||2020|2019I|
||Courses and meeting expenses|231,397|419,204|
||International
Journal ofObstetric Anaesthesia|||
||and Pencil Point Newsletter|91,767|94,170|
||Website|32,630|28,897|
||Grants (note 10)|16,627|175,650|
||Donations
(note 11)|685|311|
||External conference costs|3,235|32,384|
||Support costs (note 9)|143,041|172,022|
|||519,382|922,638|
##
|
|
||||
|---|---|---|---|---|
|NO|TES TO THE FINANCIAL STATE|MENTS|(CONTINUED)|Page 22|
|YEAR ENDED 30TH SEPTEMBER2020|||||
|8.|OTHER EXPENDlTURE||||
||||2020f|2019|
||Audit fees||7,000|6,900|
||Accountancy
fees||2,680|2,664|
||Under accrued 2018|||404|
||Legal Fees||6,560||
||Consultancy|||226|
||||16,240|10,194|
||The costs above relate to the governance|costs ofthe charity,|||
|9.|SUPPORT COSTS||||
||||2020f|2019f|
||Postage and stationery||197|6,308|
||Bank and credit card charges||8,462|14,101|
||Committee
meeting expenses||6,876|17,414|
||Membership
administration||127,506|133,999|
||Sundry|||200|
||||142,916|172,022|
|10.|GRANTS PAYABLE||||
|These constitute|commitments|made in the year|||
|---|---|---|---|---|
||||2020|2019|
|Research grants|||18,725|170,133|
|Bursaries|||1,018|18,300|
|Travelgrants|||750|3,750|
|Total grants payable|||20,493|192,183|
|Grants written back|||(3,866)|(16,533)|
|Total grants|||16,627|175,650|
##
##
|Grants to Institutions|Grants to Institutions||||
|---|---|---|---|---|
|Cambridge|University|NHS Foundation|Trust|4,985|
|||||1,748|
|Uz Leuven|—Belgium|||10,792|
|Analytics|Cambridge|Ltd||1,200|
|||||18,725|
##
##
##
|The
Executive
Committee
members
or pe
connections
have not received remuneration,|The
Executive
Committee
members
or pe
connections
have not received remuneration,|The
Executive
Committee
members
or pe
connections
have not received remuneration,|rsons
with
whom
they
have
family
directly or indirectly,
from the charity.|or business|
|---|---|---|---|---|
|During the period expenses were reimbursed|||to members ofthe Executive Committee|as follows;|
||||2020f|2019f|
|Travel and subsistence|costs refunded|to 10|members||
|(2019 - 14members)|||5,497|17,139|
##
##
##
|||||2020|2019|
|---|---|---|---|---|---|
|||||8|I|
|Opening
market|value|||1,243,357|1,168,573|
|Additions||||24,608|104,908|
|Disposals||||(102,130)|(85,378)|
|||||1,165,835|1,188,103|
|Total (toss)/gain|on revaluations||and disposals|(8,294)|55,254|
|Closing market|value|||1,157,541|1,243,357|
|Cash available to invest||||163,866|65,130|
|Total ofinvestments||||1,321,407|1,308,487|
|||||Market|Market|
|||||Value|Value|
|||||2020|2019f|
|Quoted investments||||||
|Fixed interest||||107,113|108,075|
|Equities||||851,453|973,775|
|Unit Trusts||||198,975|161,507|
|||||1,157,541|1,243,357|
|Other||||||
|Monies held by|investment|managers||163,866|65,130|
|||||1,321,407|1,308,487|
|The followin|g
re|presents
the split ofinvestments|held in the United Kingdom|and overseas:|
|---|---|---|---|---|
||||2020|2019|
||||8|8|
|Investments|held|in the United Kingdom|497,480|584,671|
|Investments|held|overseas|660,061|658,685|
||||1,157,541|1,243,357|
##
|YE|AR ENDED 3|0TH SEPTEMBER 2020|||
|---|---|---|---|---|
|15.|DEBTORS||||
||||2020|2019|
||||8||
||Trade debtors||1,500|1,200|
||Other debtors||3,960|7,584|
||Prepayments|and accrued income|252,273|206,775|
||||257,733|215,559|
##
|REDITORS: AMOUNTS FALLING D|UE WITHIN ONE YEAR||
|---|---|---|
||2020|2019|
|Trade creditors|43,437|54,204|
|Grants payable (note 17)|49,562|153,814|
|Deferred income|71,256|209,665|
|Accrued expenses|89,043|82,789|
||253,298|500,472|
##
|ECONCILIATION
OF GRANT COMMITMENT|S||
|---|---|---|
||2020|2019|
|||8|
|Balance owing at 1stOctober 2019|153,814|96,901|
|Commitments
made in period (note 10)|20,493|192,183|
|Registration
fees waived|||
|Grants written back (note 10)|(3,866)|(16,533)|
|Payments
in period|(120,879)|(118,737)|
|Balance owing at 30th September 2020 (note 16)|49,562|153,814|
##
##
##
|||||Designated|Funds|Funds|General|Total|
|---|---|---|---|---|---|---|---|---|
||||||||Fund||
||||Infrastructure|Grants||Unrealised|||
||||Fund|Fund||Gsias on|||
|||||||Investments|||
|At 1stOctober 2019|||150,000|999,485||309,002|120,754|1,579,241|
|Net incoming/(outgoing)|resources||||||||
|for the period|||||||49,856|49,856|
|Transfer grants committed||in period||(20,493)|||20,493||
|Transfer offunds as designated|||grants|41,707|||(41,707)||
|Total profit on revaluations||and|||||||
|disposal ofinvestment|assets|||||(8,294)||(8,294)|
|At 30th September 2020|||150,000|1,020,699||300,708|149,396|1,620,803|
##
|Unrestricte|d
funds a|t 30|Se|ptember 2019|ptember 2019||||
|---|---|---|---|---|---|---|---|---|
|||||Designated||Funds|General|Total|
||||||||Fund||
|||||Infrastructure|Grants|Unresllsed|||
|||||Fund|Fund|Gains on|||
|||||||Investments|||
|At 1st October 2018||||150,000|968,680|253,748|286,790|1,659,218|
|Nut uutgoing|resources|for|the|period|||(135,231)|(135,231)|
|Transfer grants committed|||in period||(192,183)||192,183||
|Transfer of|funds as designated|||grants|222,988||(222,988)||
|Total profit|on revaluations||and||||||
|disposal ofinvestment||assets||||55,254||55,254|
|At 30th September 2019||||150,000|999,485|309,002|120,754|1,579,241|
##
##
##
|Year ended 30Septembe|r 2020|||||
|---|---|---|---|---|---|
||lafrsstructure|Grants|Unrealised|General|Total|
||Fund|Fund|gains an|Fund||
||(Desigasted)|(Designated)|investments|||
||||(Designated)|||
|Investments||1,020,699|300,708||1,321,407|
|Debtors||||257,733|257,733|
|Short term deposits and||||||
|cash balances|150,000|||144,961|294,961|
|Creditors||||(253498)|(253,298)|
||150,000|1,020,699|300,708|149,396|1,620,803|
|Year ended 30September|2019|||||
||Infrastructure|Grants|Uareslised|General|Total|
||Fund|Fund|gains on|Fund||
||(Designated)|(Designated)|Investments|||
||||(Designated)|||
|Investments||999,485|309,002||1,308,487|
|Debtors||||215,559|215,559|
|Short term deposits and||||||
|cash balances|150,000|||405,667|555,667|
|Creditors||||(500,472)|(500,472)|
||150,000|999,485|309,002|120,754|1,579,241|
##
##
|RECONCILIATIO
ACTIVITIES|N OFNET|INCOME TO|NET CASH FLOW FROM|OPERATING|
|---|---|---|---|---|
||||2020|2019|
||||8||
|Net income/(loss)|for the year||41,562|(79,977)|
|(Losses)/gains
on investments|||8,294|(55354)|
|Dividends
received|||(32,848)|(37,686)|
|(Increase)/decrease|in debtors||(42,174)|39,367|
|(Decrease)iincrease|in creditors||(247,174)|44,128|
|Net cash flow from operating||activities|(272,340)|(89,422)|